🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To learn if the combination of DKN-01 and pembrolizumab can help to control...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-08-29
Trial ID
NCT05761951
Treatments Being Tested
In this study, non-operable esophagogastric adenocarcinoma cancer patients ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-12
Trial ID
NCT03818997
Treatments Being Tested
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Status
Terminated
Location
Mayo Clinic Cancer Center
Start Date
2020-07-29
Trial ID
NCT04363801
This is a non-randomized multi-center Phase 1b/2a dose escalation and dose ...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-04-01
Trial ID
NCT03837353
This research is studying the effect of the combination of how two study dr...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2019-10-07
Trial ID
NCT04057365
A study to evaluate the safety and tolerability of DKN-01 in combination wi...
Status
Completed
Location
Cedars Sinai Medical Care Foundation
Start Date
2014-05-05
Trial ID
NCT02013154
Treatments Being Tested
A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monothera...
Status
Completed
Location
University of Alabama
Start Date
2018-03-05
Trial ID
NCT03395080
Treatments Being Tested
An Expanded Access Protocol for use of DKN-01 for the treatment of advanced...
Status
No Longer Available
Location
University of Alabama
Start Date
TBD
Trial ID
NCT04681248
Treatments Being Tested
A study to evaluate the safety, efficacy and bone changes with combination ...
Status
Completed
Location
Emory University Hospital
Start Date
2013-05
Trial ID
NCT01711671
Treatments Being Tested
This is a Phase 2 randomized, open-label, two-part, multicenter study with ...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2022-08-30
Trial ID
NCT05480306
Treatments Being Tested